These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25908108)

  • 1. Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome.
    Kankaya D; Kiremitci S; Tulunay O; Baltaci S
    Pathol Res Pract; 2015 Jul; 211(7):505-12. PubMed ID: 25908108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of epidermal growth factor receptor on clear cell renal cell carcinoma: Does it change with different expression patterns?
    Kankaya D; Kiremitci S; Tulunay O; Baltaci S
    Indian J Pathol Microbiol; 2016; 59(1):35-40. PubMed ID: 26960632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
    Lee C; Park JW; Suh JH; Moon KC
    Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
    Huang C; Huang K; Wang C; Jiang ZD; Li XX; Wang HP; Chen HY
    Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.
    Bai Q; Liu L; Long Q; Xia Y; Wang J; Xu J; Guo J
    Int J Clin Exp Pathol; 2015; 8(9):11005-14. PubMed ID: 26617818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
    Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
    Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
    Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
    Nariai Y; Mishima K; Yoshimura Y; Sekine J
    Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
    Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
    Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
    Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
    Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis.
    Li G; Forest F; Feng G; Gentil-Perret A; Péoc'h M; Cottier M; Mottet N
    Urol Oncol; 2014 Nov; 32(8):1272-6. PubMed ID: 24996774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomy.
    Voutsadakis IA; Vlachostergios PJ; Daliani DD; Karasavvidou F; Kakkas G; Moutzouris G; Melekos MD; Papandreou CN
    Urol Int; 2012; 88(2):158-64. PubMed ID: 22286396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of a large patient sample to determine p53 and Ki67 expressions in renal cell carcinoma.
    Zheng K; Zhu W; Tan J; Wu W; Yang S; Zhang J
    J BUON; 2014; 19(2):512-6. PubMed ID: 24965414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
    Karakiewicz PI; Trinh QD; Rioux-Leclercq N; de la Taille A; Novara G; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Lechevallier E; Coulange C; Valeri A; Descotes JL; Rambeaud JJ; Abbou CC; Lang H; Jacqmin D; Mejean A; Patard JJ
    Eur Urol; 2007 Oct; 52(4):1140-5. PubMed ID: 17336449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.